The glucose sensor ChREBP links de novo lipogenesis to PPARγactivity and adipocyte differentiation

Endocrinology (United States)

Volumn 156, Issue 11, 2015, Pages 4008-4019

  Witte, Nicole ^a   Muenzner, Matthias ^a   Rietscher, Janita ^a   Knauer, Miriam ^a   Heidenreich, Steffi ^a   Nuotio Antar, Alli M ^b   Graef, Franziska A ^a   Fedders, Ronja ^a   Tolkachov, Alexander ^a   Goehring, Isabel ^a   Schupp, Michael ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CARBOHYDRATE RESPONSE ELEMENT BINDING PROTEIN; FATTY ACID; FATTY ACID SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; GLUCOSE; ISOPROTEIN; MLXIPL PROTEIN, MOUSE; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR;

ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; CELL DIFFERENTIATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EX VIVO STUDY; EXPOSURE VARIABLE; GENE TARGETING; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIPOGENESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; THERMOGENESIS; 3T3 CELL LINE; ANIMAL; CELL LINE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HEK293 CELL LINE; IMMUNOBLOTTING; MESENCHYMAL STROMA CELL; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION; GLUCOSE; HEK293 CELLS; HUMANS; IMMUNOBLOTTING; LIPOGENESIS; MESENCHYMAL STROMAL CELLS; MICE; NUCLEAR PROTEINS; PPAR GAMMA; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTION FACTORS;

EID: 84946100121     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/EN.2015-1209     Document Type: Article

References (65)

1. Li MV, Chen W, Harmancey RN, et al. Glucose-6-phosphate mediates activation of the carbohydrate responsive binding protein (ChREBP). Biochem Biophys Res Commun. 2010;395:395-400.
2. Dentin R, Tomas-Cobos L, Foufelle F, et al. Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver. J Hepatol. 2012;56: 199-209.
3. Kabashima T, Kawaguchi T, Wadzinski BE, Uyeda K. Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-Activated protein phosphatase in rat liver. Proc Natl Acad Sci USA. 2003;100:5107-5112.
4. Stoeckman AK, Ma L, Towle HC. Mlx is the functional heteromeric partner of the carbohydrate response element-binding protein in glucose regulation of lipogenic enzyme genes. J Biol Chem. 2004; 279:15662-15669.
5. Yamashita H, Takenoshita M, Sakurai M, et al. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci USA. 2001;98:9116-9121.
6. Iizuka K, Bruick RK, Liang G, Horton JD, Uyeda K. Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proc Natl Acad Sci USA. 2004; 101:7281-7286.
7. Herman MA, Peroni OD, Villoria J, et al. A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature. 2012;484:333-338.
8. Benhamed F, Denechaud PD, Lemoine M, et al. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. J Clin Invest. 2012;122:2176-2194.
9. Iizuka K, Miller B, Uyeda K. Deficiency of carbohydrate-Activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice. Am J Physiol En-docrinol Metab. 2006;291:E358-E364.
10. Dentin R, Benhamed F, Hainault I, et al. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes. 2006;55:2159-2170.
11. Shepherd PR, Kahn BB. Glucose transporters and insulin action-implications for insulin resistance and diabetes mellitus. N Engl J Med. 1999;341:248-257.
12. Eissing L, Scherer T, Todter K, et al. De novo lipogenesis in human fat and liver is linked to ChREBP-/3 and metabolic health. Nat Com-mun. 2013;4:1528.
13. Kursawe R, Caprio S, Giannini C, et al. Decreased transcription of ChREBP-A//3 isoforms in abdominal subcutaneous adipose tissue of obese adolescents with prediabetes or early type 2 diabetes: associations with insulin resistance and hyperglycemia. Diabetes. 2013; 62:837-844.
14. Yore MM, Syed I, Moraes-Vieira PM, et al. Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects. Cell. 2014;159:318-332.
15. Lehrke M, Lazar M.A. The many faces of PPAR7. Cell. 2005;123: 993-999.
16. Chawla A, Schwarz EJ, Dimaculangan DD, Lazar M.A. Peroxisome proliferator-Activated receptor (PPAR) 7: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology. 1994;135:798-800.
17. Muenzner M, Tuvia N, Deutschmann C, et al. Retinol-binding protein 4 and its membrane receptor STRA6 control adipogenesis by regulating cellular retinoid homeostasis and retinoic acid receptor a activity. Mol Cell Biol. 2013;33:4068-4082.
18. Pear WS, Nolan GP, Scott ML, Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA. 1993;90:8392-8396.
19. Schupp M, Lefterova MI, Janke J, et al. Retinol saturase promotes adipogenesis and is downregulated in obesity. Proc Natl Acad Sci USA. 2009;106:1105-1110.
20. Boergesen M, Poulsen Ll, Schmidt SF, Frigerio F, Maechler P, Man-drup S. ChREBP mediates glucose repression of peroxisome proliferator-Activated receptor a expression in pancreatic/3-cells. J Biol Chem. 2011;286:13214-13225.
21. Tsatsos NG, Davies MN, O'Callaghan BL, Towle HC. Identification and function of phosphorylation in the glucose-regulated transcription factor ChREBP. Biochem J. 2008;411:261-270.
22. Schupp M, Janke J, Clasen R, Unger T, Kintscher U. Angiotensin type 1 receptor blockers induce peroxisome proliferator-Activated receptor-7 activity. Circulation. 2004;109:2054-2057.
23. Tsatsos NG, Towle HC. Glucose activation of ChREBP in hepato-cytes occurs via a two-step mechanism. Biochem Biophys Res Com-mun. 2006;340:449-456.
24. Fried SK, Moustaid-Moussa N. Culture of adipose tissue and isolated adipocytes. Methods Mol Biol. 2001;155:197-212.
25. Green H, Meuth M. An established pre-Adipose cell line and its differentiation in culture. Cell. 1974;3:127-133.
26. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM. mP-PAR 7 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 1994;8:1224-1234.
27. Li J, Takaishi K, Cook W, McCorkle SK, Unger RH. Insig-1 "brakes" lipogenesis in adipocytes and inhibits differentiation of preadipocytes. Proc Natl Acad Sci USA. 2003;100:9476-9481.
28. He Z, Jiang T, Wang Z, Levi M, Li J. Modulation of carbohydrate response element-binding protein gene expression in 3T3-L1 adipocytes and rat adipose tissue. Am J Physiol Endocrinol Metab. 2004;287:E424-E430.
29. Hurtado del Pozo C, Vesperinas-García G, Rubio MÁ, et al. ChREBP expression in the liver, adipose tissue and differentiated preadipocytes in human obesity. Biochim Biophys Acta. 2011;1811: 1194-1200.
30. Schupp M, Cristancho AG, Lefterova MI, et al. Re-expression of GATA2 cooperates with peroxisome proliferator-Activated receptor-7 depletion to revert the adipocyte phenotype. J Biol Chem. 2009;284:9458-9464.
31. Ge Q, Huang N, Wynn RM, et al. Structural characterization of a unique interface between carbohydrate response element-binding protein (ChREBP) and 14-3-3/3 protein. J Biol Chem. 2012;287: 41914-41921.
32. Filhoulaud G, Guilmeau S, Dentin R, Girard J, Postic C. Novel insights into ChREBP regulation and function. Trends Endocrinol Metab. 2013;24:257-268.
33. Jeong YS, Kim D, Lee YS, et al. Integrated expression profiling and genome-wide analysis of ChREBP targets reveals the dual role for ChREBP in glucose-regulated gene expression. PLoS One. 2011;6: e22544.
34. Sul HS, Smas CM, Wang D, Chen L. Regulation of fat synthesis and adipose differentiation. Prog Nucleic Acid Res Mol Biol. 1998;60: 317-345.
35. Tong Q, Dalgin G, Xu H, Ting CN, Leiden JM, Hotamisligil GS. Function of GATA transcription factors in preadipocyte-Adipocyte transition. Science. 2000;290:134-138.
36. Kim JB, Wright HM, Wright M, Spiegelman BM. ADD1/SREBP1 activates PPAR7 through the production of endogenous ligand. Proc Natl Acad Sci USA. 1998;95:4333-4337.
37. Lodhi IJ, Yin L, Jensen-Urstad AP, et al. Inhibiting adipose tissue lipogenesis reprograms thermogenesis and PPAR7 activation to decrease diet-induced obesity. Cell Metab. 2012;16:189-201.
38. Xue JC, Schwarz EJ, Chawla A, Lazar M.A. Distinct stages in adi-pogenesis revealed by retinoid inhibition of differentiation after induction of PPAR7. Mol Cell Biol. 1996;16:1567-1575.
39. Schmid B, Rippmann JF, Tadayyon M, Hamilton BS. Inhibition of fatty acid synthase prevents preadipocyte differentiation. Biochem Biophys Res Commun. 2005;328:1073-1082.
40. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-Activated receptor 7 (PPAR 7). J Biol Chem. 1995;270:12953-12956.
41. Schupp M, Clemenz M, Gineste R, et al. Molecular characterization of new selective peroxisome proliferator-Activated receptor 7 modulators with angiotensin receptor blocking activity. Diabetes. 2005; 54:3442-3452.
42. Chui PC, Guan HP, Lehrke M, Lazar M.A. PPAR7 regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1. J Clin Invest. 2005;115:2244-2256.
43. Bugge A, Siersbaek M, Madsen MS, Göndör A, Rougier C, Man-drup S. A novel intronic peroxisome proliferator-Activated receptor y enhancer in the uncoupling protein (UCP) 3 gene as a regulator of both UCP2 and-3 expression in adipocytes. J Biol Chem. 2010; 285:17310-17317.
44. Wilson-Fritch L, Nicoloro S, Chouinard M, et al. Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J Clin Invest. 2004;114:1281-1289.
45. Viswakarma N, Yu S, Naik S, et al. Transcriptional regulation of Cidea, mitochondrial cell death-inducing DNA fragmentation factor a-like effector A, in mouse liver by peroxisome proliferator-Activated receptor a and 7. J Biol Chem. 2007;282:18613-18624.
46. Camp HS, Chaudhry A, Leff T. A novel potent antagonist of peroxisome proliferator-Activated receptor 7 blocks adipocyte differentiation but does not revert the phenotype of terminally differentiated adipocytes. Endocrinology. 2001;142:3207-3213.
47. Cao H, Gerhold K, Mayers JR, Wiest MM, Watkins SM, Hotamisligil GS. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell. 2008;134:933-944.
48. Lodhi IJ, Wei X, Semenkovich CF. Lipoexpediency: de novo lipogenesis as a metabolic signal transmitter. Trends Endocrinol Metab. 2011;22:1-8.
49. Waku T, Shiraki T, Oyama T, Maebara K, Nakamori R, Morikawa K. The nuclear receptor PPAR7 individually responds to serotonin-And fatty acid-metabolites. EMBO J. 2010;29:3395-3407.
50. Schupp M, Lazar M.A. Endogenous ligands for nuclear receptors: digging deeper. J Biol Chem. 2010;285:40409-40415.
51. Homan EA, Kim YG, Cardia JP, Saghatelian A. Monoalkylglycerol ether lipids promote adipogenesis. J Am Chem Soc. 2011;133: 5178-5181.
52. Shabalina IG, Ost M, Petrovic N, Vrbacky M, Nedergaard J, Cannon B. Uncoupling protein-1 is not leaky. Biochim Biophys Acta. 2010;1797:773-784.
53. Fisher FM, Kleiner S, Douris N, et al. FGF21 regulates PGC-1 a and browning of white adipose tissues in adaptive thermogenesis. Genes Dev. 2012;26:271-281.
54. Iizuka K, Takeda J, Horikawa Y. Glucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytes. FEBS Lett. 2009;583:2882-2886.
55. Muise ES, Azzolina B, Kuo DW, et al. Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-Activated receptor 7 and altered metabolic states. Mol Pharmacol. 2008;74: 403-412.
56. Dutchak PA, Katafuchi T, Bookout AL, et al. Fibroblast growth factor-21 regulates PPAR7 activity and the antidiabetic actions of thiazolidinediones. Cell. 2012;148:556-567.
57. Higgins LS, Depaoli AM. Selective peroxisome proliferator-Activated receptor 7 (PPAR7) modulation as a strategy for safer therapeutic PPAR7 activation. Am J Clin Nutr. 2010;91:267S-272S.
58. Choi JH, Banks AS, Kamenecka TM, et al. Antidiabetic actions of a non-Agonist PPAR7 ligand blocking Cdk5-mediated phosphorylation. Nature. 2011;477:477-481.
59. Stewart WC, Baugh JE Jr, Floyd ZE, Stephens JM. STAT 5 activators can replace the requirement of FBS in the adipogenesis of 3T3-L1 cells. Biochem Biophys Res Commun. 2004;324:355-359.
60. Mackall JC, Student AK, Polakis SE, Lane MD. Induction of lipogenesis during differentiation in a "preadipocyte" cell line. J Biol Chem. 1976;251:6462-6464.
61. Levert KL, Waldrop GL, Stephens JM. A biotin analog inhibits acetyl-CoA carboxylase activity and adipogenesis. J Biol Chem. 2002;277:16347-16350.
62. Sánchez-Solana B, Li DQ, Kumar R. Cytosolic functions of MORC2 in lipogenesis and adipogenesis. Biochim Biophys Acta. 2014;1843: 316-326.
63. Liu LH, Wang XK, Hu YD, Kang JL, Wang LL, Li S. Effects of a fatty acid synthase inhibitor on adipocyte differentiation of mouse 3T3-L1 cells. Acta Pharmacol Sin. 2004;25:1052-1057.
64. Christianson JL, Nicoloro S, Straubhaar J, Czech MP. Stearoyl-CoA desaturase 2 is required for peroxisome proliferator-Activated receptor 7 expression and adipogenesis in cultured 3T3-L1 cells. J Biol Chem. 2008;283:2906-2916.
65. Li MV, Chen W, Poungvarin N, Imamura M, Chan L. Glucose-mediated transactivation of carbohydrate response element-binding protein requires cooperative actions from Mondo conserved regions and essential trans-Acting factor 14-3-3. Mol Endocrinol. 2008;22: 1658-1672.